The Latest: Dortmund bus attack suspect bet against the team

Associated Press |

BERLIN (AP) — The Latest on the Borussia Dortmund team bus bombing (all times local):

German prosecutors say the 28-year-old man arrested on suspicion of attacking the Borussia Dortmund team bus had taken out a five-figure loan to bet on a drop in the clubs' stock by purchasing financial derivatives.

Spokeswoman Frauke Koehler says investigators are still trying to determine how big a profit the suspect might have made.

Koehler said in a statement Friday that the German-Russian dual citizen, identified only as Sergej W., bought most of the financial derivatives on , the day of the attack.

The prosecutors said there were no indications that the suspect was aided by others.



A 28-year-old German-Russian citizen was arrested Friday in Germany on suspicion of bombing the bus carrying the Borussia Dortmund soccer team in an attack last week that officials alleged was motivated by financial greed.

A Dortmund player and a policeman were injured in the triple blasts as the bus was heading to the team's stadium for a Champions League game. Investigators found notes at the scene claiming responsibility on behalf of Islamic extremists, but quickly doubted their authenticity.

Federal prosecutors said the suspect, identified only as Sergej W. in keeping with German privacy law, was arrested early Friday in or near the southwestern city of Tuebingen. He faces charges of attempted murder, causing an explosion and serious bodily harm.

Prosecutors said he had taken out a loan and bought a large number of put options for shares of Borussia Dortmund, betting on a drop in the share price.

"A significant share price drop could have been expected if a player had been seriously injured or even killed as a result of the attack," they said.

Ralf Jaeger, the top security official in North Rhine-Westphalia state, said the suspect had hoped to earn millions.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…